Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:383494.
doi: 10.1155/2014/383494. Epub 2014 Jun 4.

Correlation between behavioural and psychological symptoms of Alzheimer type dementia and plasma homocysteine concentration

Zhanjie Zheng  1 , Jindong Wang  1 , Lei Yi  1 , Hui Yu  1 , Lingli Kong  1 , Weizhen Cui  1 , Hong Chen  1 , Chunxia Wang  2
Affiliations

Correlation between behavioural and psychological symptoms of Alzheimer type dementia and plasma homocysteine concentration

Zhanjie Zheng et al. Biomed Res Int. 2014.

Abstract

The relationship between plasma homocysteine and behavioral and psychological symptoms of dementia (BPSD) has not been specifically investigated in previous research. In this study, we compared plasma homocysteine (Hcy) among 40 Alzheimer's disease (AD) patients with BPSD, 37 AD patients without BPSD, and 39 healthy controls. Our results evidenced that the plasma homocysteine levels in AD patients with BPSD and without BPSD were higher than healthy controls and that the plasma homocysteine concentration in AD patients with BPSD was the highest among the three groups. Significant correlation between plasma homocysteine concentration and cognitive decline and duration of dementia was observed, but there was no correlation between BPSD and cognitive dysfunction or duration of dementia. In conclusion, this study showed for the first time that BPSD were associated with plasma homocysteine concentration in Alzheimer's dementia, and the results supported that hyperhomocysteine may take part in the pathogenesis of BPSD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The correlations between MMSE and homocysteine in AD patients. (a) A significant negative correlation between MMSE and homocysteine in BPSD patients group (r = 0.974; P < 0.001). (b) A significant negative correlation between MMSE and homocysteine in No BPSD patients group (r = 0.929; P < 0.001). Correlation lines are also shown.
Figure 2
Figure 2
The correlations between duration of AD and homocysteine in AD patients. (a) A significant positive correlation between duration of AD and homocysteine in BPSD patients group (r = 0.988; P < 0.001). (b) A significant positive correlation between duration of AD and homocysteine in No BPSD patients group (r = 0.974; P < 0.001). Correlation lines are also shown.
See this image and copyright information in PMC

References

    1. Fuentealba RA, Farias G, Scheu J, Bronfman M, Marzolo MP, Inestrosa NC. Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease. Brain Research Reviews. 2004;47(1–3):275–289. - PubMed
    1. Association IP. Research methodological issue in evaluating behavioral disorders of dementia. International Psychogeriatrics. 1996;8(3):215–218. - PubMed
    1. Qu HF, Zhang H, Sheng JH, Gao ZX. Comparison of the behavioral disorder in Alzheimer's disease and vascular dementia patients. Journal of Clinical Psychological Medicine. 2003;13(5):287–288.
    1. Tariot P, Blazina L. The psychopathology of dementia. Neurological Disease and Therapy. 1994;22(1):p. 461.
    1. Wei J, Li HW. Progress in clinical research of Alzheimer's disease. Journal of Qiqihar Medical College. 2008;29(21):p. 2633.